Morgan Stanley’s SANUWAVE Health Inc SNWV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Buy
31,619
+25,826
+446% +$400K ﹤0.01% 5755
2026
Q1
$100K Sell
5,793
-7,034
-55% -$174K ﹤0.01% 6163
2025
Q4
$383K Buy
12,827
+5,664
+79% +$182K ﹤0.01% 5650
2025
Q3
$268K Sell
7,163
-2,260
-24% -$83.7K ﹤0.01% 5767
2025
Q2
$310K Sell
9,423
-195,544
-95% -$5.91M ﹤0.01% 5675
2025
Q1
$7.25M Buy
+204,967
New +$6.72M ﹤0.01% 3611

Other funds holding SNWV

Morgan Stanley's SNWV Position: Q2 2026 in Review

Morgan Stanley increased its SANUWAVE Health Inc (SNWV) stake by 446% in Q2 2026, buying an estimated $400K and bringing the position to 31,619 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #5755.

Morgan Stanley first reported a position in SNWV in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.25M in Q1 2025. 49 funds tracked by Wall St. Rank hold SNWV as of Q2 2026.

  • Morgan Stanley held 31,619 shares of SANUWAVE Health Inc worth $316K as of Q2 2026.
  • Morgan Stanley bought 25,826 SANUWAVE Health Inc shares in Q2 2026, an estimated $400K.
  • SANUWAVE Health Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5755 holding.
  • Morgan Stanley first reported a position in SANUWAVE Health Inc in Q1 2025 and has held it in 6 quarters since.
  • Morgan Stanley's SANUWAVE Health Inc position peaked at $7.25M in Q1 2025.
  • 49 funds tracked by Wall St. Rank held SANUWAVE Health Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.